Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
1.25M
-
Shares change
-
+147K
-
Total reported value, excl. options
-
$3.05M
-
Value change
-
+$325K
-
Put/Call ratio
-
2.11
-
Number of buys
-
14
-
Number of sells
-
-8
-
Price
-
$2.45
Significant Holders of Acurx Pharmaceuticals, Inc. - COM (ACXP) as of Q1 2024
32 filings reported holding ACXP - Acurx Pharmaceuticals, Inc. - COM as of Q1 2024.
Acurx Pharmaceuticals, Inc. - COM (ACXP) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.25M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (492K shares), Prospect Financial Services LLC (273K shares), GEODE CAPITAL MANAGEMENT, LLC (116K shares), OSAIC HOLDINGS, INC. (57.3K shares), STATE STREET CORP (43.5K shares), LPL Financial LLC (40.2K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (37.4K shares), MORGAN STANLEY (26.4K shares), BlackRock Inc. (18.7K shares), and TD Waterhouse Canada Inc. (18.7K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.